Human trial
Primary evidence or regulator source
Healthy volunteers and Cushing syndrome patients
Reported findings. ACTH/cortisol/GH responses
Nonresponse. Recovery or muscle benefit not assessed
Harms. Hormone effects are not safety clearance
Limits. No transfer to other routes/formulations/indications; clinician review pending.
Preparation: Hexarelin trial preparation Route: intravenous
Read original source ↗Editorial review 2026-10-09. Clinician review pending.